December 15, 2025 · Form 4 insider transaction
Goodrich Katherine bought 2,233 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 30 days after the transaction.
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.